Skip to content

Study on the Effect of Zinc Supplement on Methadone Therapy Dosage, Sleep, Mental Health and Relapse Probability of Drug Abusers

Study on the Effect of Zinc Supplement on Methadone Therapy Dosage, Sleep, Mental Health and Relapse Probability of Drug Abusers

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200509047361N1
Enrollment
80
Registered
2020-10-09
Start date
2020-09-22
Completion date
Unknown
Last updated
2020-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Methadone-treated addicts. Opioid related disorders

Interventions

Intervention 1: Intervention group: After estimating the sample size, 40 drug users with a history of methadone use for at least three months were randomly admitted to the intervention group with writ
. Intervention 2: Control group: Control group: After estimating the sample size, 40 drug users with a history of methadone use for at least three months were randomly included in the control group. W

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Willingness to participate in research Age over 18 years They are reading and writing. A positive urine test confirmed drug abuse. Methadone was used under the supervision of a doctor three months ago.

Exclusion criteria

Exclusion criteria: Use of zinc-containing compounds before intervention Change in treatment protocol Have acute mental disorders, such as silicosis and bipolar schizophrenia

Design outcomes

Primary

MeasureTime frame
Sleep. Timepoint: Before the start of the study, one month and three months after the start of the study. Method of measurement: Pittsburgh Sleep Questionnaire.;Mental health status. Timepoint: Before the start of the study, one month and three months after the start of the study. Method of measurement: Mental Health Questionnaire.;Dosage of the drug use. Timepoint: Before the start of the study, one month and three months after the start of the study. Method of measurement: The dose was recorded before the study, the dose was recorded during the study, and Wright Self-Assessment Scale was applied.

Secondary

MeasureTime frame
Return from methadone addiction. Timepoint: ??? ?? ???? ?????? ??? ??? ? ?? ??? ????? ??????. Method of measurement: Record the dose consumed by the researcher.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Zahra Amini

Esfahan University of Medical Sciences

zahraamini63@gmail.com+98 31 3792 8110

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026